Benzinga What's Going On With Immunome Shares Monday?
Immunome shares trade higher on Monday after the company announced results from the global pivotal Phase 3 RINGSIDE trial of varegcasetat and met its primary endpoint. read more
Immunome shares trade higher on Monday after the company announced results from the global pivotal Phase 3 RINGSIDE trial of varegcasetat and met its primary endpoint. read more